Brief: Xbrane Biopharma Q3 EBITDA SEK -81.6 Million

Xbrane Biopharma AB

30/11/2023 07:00

Nov 30 (Reuters) - Xbrane Biopharma Q3 EPS SEK -2.78.
* Q3 net income SEK -81.2 million
* Q3 revenue SEK 58.9 million